Business of Biotech Conference 2018

Friday | 3.2.2018 | Moffitt Cancer Center


 

KEYNOTE
FRANCIS CUSS,  MB BChir, FRCP

Former Chief Scientific Officer of Bristol-Myers Squibb and a physician with broad experience in pharmaceutical research and development.  He has played a leading role in the development of the immuno-oncology drug Opdivo (Nivolumab; anti-PD-1 monoclonal antibody).

INTERVIEWER
COKIE ROBERTS

ABC News Political Commentator,
Contributing Senior News Analyst - NPR,
and Member of the Moffitt Cancer Center
National Board of Advisors conducts a
conversation with Dr. Cuss.

FILL TEXT WHITE TO MAKE SPACE

FILL

HIGHLIGHTS FROM THE 2017 CONFERENCE